Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates

Annals of Emergency Medicine

Volumn 62, Issue 6, 2013, Pages

  Frumkin, Kenneth ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; FRESH FROZEN PLASMA; PHYTOMENADIONE; PROTHROMBIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 9; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; ARTICLE; BLEEDING; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DECOMPENSATED LIVER CIRRHOSIS; DRUG COST; DRUG HALF LIFE; DRUG SAFETY; EMERGENCY WARD; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMOPHILIA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; MORTALITY; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOSIS; TREATMENT CONTRAINDICATION; UNITED STATES;

EID: 84888129052     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2013.05.026     Document Type: Article

References (226)

1. A.M. Holbrook, J.A. Pereira, and R. Labiris Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 2005 1095 1106
2. R.G. Hart, B.S. Boop, and D.C. Anderson Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses Stroke 26 1995 1471 1477
3. S.M. Davis, J. Broderick, and M. Hennerici Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage Neurology 66 2006 1175 1181
4. J.J. Flibotte, N. Hagan, and J. O'Donnell Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage Neurology 63 2004 1059 1064
5. B. Cucchiara, S. Messe, and L. Sansing Hematoma growth in oral anticoagulant related intracerebral hemorrhage Stroke 39 2008 2993 2996
6. L. Sjoblom, H.G. Hardemark, and A. Lindgren Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study Stroke 32 2001 2567 2574
7. R. Sarode, and K. Matevosyan Prothrombin complex concentrate and fatal thrombosis: poor evidence to implicate a relatively safe drug Ann Emerg Med 54 2009 481 482 author reply 482-483
8. D.K. Nishijima, W.E. Dager, and R.J. Schrot The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage Acad Emerg Med 17 2010 244 251
9. O. Warren, and B. Simon Massive, fatal, intracardiac thrombosis associated with prothrombin complex concentrate Ann Emerg Med 53 2009 758 761
10. C. Wojcik, M.L. Schymik, and E.G. Cure Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy Int J Emerg Med 2 2009 217 225
11. M. Levi Emergency reversal of antithrombotic treatment Intern Emerg Med 4 2009 137 145
12. B.F. Bechtel, T.C. Nunez, and J.A. Lyon Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review Int J Emerg Med 4 2011 40
13. M. Zareh, A. Davis, and S. Henderson Reversal of warfarin-induced hemorrhage in the emergency department West J Emerg Med 12 2011 386 392
14. J.N. Goldstein Beriplex outperforms plasma for rapid warfarin reversal Presented at: the Scientific Assembly of the American College of Emergency Physicians. Denver, CO: October 8-11, 2012 http://www.acepnews.com/specialty- focus/toxicology/single-article-page/beriplex-outperforms-plasma-for-rapid- warfarin-reversal/f841ecd78971e82c1fb2ec9ad5dec4fc.html Accessed March 3, 2013
15. J. Ferreira, and M. Delossantos The clinical use of prothrombin complex concentrate J Emerg Med. 44 2013 1201 1210
16. M. Yasaka, T. Sakata, and K. Minematsu Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication Thromb Res 108 2003 25 30
17. K.J. Dezee, W.T. Shimeall, and K.M. Douglas Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis Arch Intern Med 166 2006 391 397
18. H.G. Watson, T. Baglin, and S.L. Laidlaw A comparison of the efficacy and rate of response to oral and intravenous vitamin K in reversal of over-anticoagulation with warfarin Br J Haematol 115 2001 145 149
19. A. Lubetsky, H. Yonath, and D. Olchovsky Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study Arch Intern Med 163 2003 2469 2473
20. T.P. Baglin, D.M. Keeling, and H.G. Watson Guidelines on oral anticoagulation (warfarin): third edition - 2005 update Br J Haematol 132 2005 277 285
21. A. Holbrook, S. Schulman, and D.M. Witt Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e152S e184S
22. D.L. Riegert-Johnson, and G.W. Volcheck The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review Ann Allergy Asthma Immunol 89 2002 400 406
23. B. Ozgonenel, B. O'Malley, and P. Krishen Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital Am J Hematol 82 2007 1091 1094
24. J.D. Roback, S. Caldwell, and J. Carson Evidence-based practice guidelines for plasma transfusion Transfusion 50 2010 1227 1239
25. S.J. Stanworth, J. Grant-Casey, and D. Lowe The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children Transfusion 51 2011 62 70
26. P. Chowdhury, A.G. Saayman, and U. Paulus Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients Br J Haematol 125 2004 69 73
27. D.L. Brody, V. Aiyagari, and A.M. Shackleford Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage Neurocrit Care 2 2005 263 267
28. C.V. Brown, K.H. Foulkrod, and D. Lopez Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients J Trauma 68 2010 348 352
29. C. Ilyas, G.M. Beyer, and R.P. Dutton Recombinant factor VIIa for warfarin-associated intracranial bleeding J Clin Anesth 20 2008 276 279
30. B. Roitberg, O. Emechebe-Kennedy, and S. Amin-Hanjani Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study Neurosurgery 57 2005 832 836 discussion 832-836
31. D.M. Stein, R.P. Dutton, and J.R. Hess Low-dose recombinant factor VIIa for trauma patients with coagulopathy Injury 39 2008 1054 1061
32. D.M. Stein, R.P. Dutton, and M.E. Kramer Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury J Trauma 64 2008 620 627 discussion 627-628
33. S.B. Lee, E.M. Manno, and K.F. Layton Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP Neurology 67 2006 1272 1274
34. J. Menzin, L.A. White, and M. Friedman Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding An analysis of electronic health records Thromb Haemost 107 2012 662 672
35. J.N. Goldstein, S.H. Thomas, and V. Frontiero Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage Stroke 37 2006 151 155
36. W. Ageno, D. Garcia, and M.I. Aguilar Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: treatment Am J Hematol 84 2009 584 588
37. R.I. Baker, P.B. Coughlin, and A.S. Gallus Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis Med J Aust 181 2004 492 497
38. L.B. Morgenstern, J.C. Hemphill 3rd, and C. Anderson Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 41 2010 2108 2129
39. M. Kaste, H. Kwiecinski, and T. Steiner Slide-kit "Recommendations for the diagnosis and treatment of intracerebral haemorrhage 2006" European Stroke Organisation web site http://www.eso-stroke.org/lectures/EUSI-ICH- Recommendations-US/player.html Accessed December 4, 2011
40. J.N. Goldstein, J. Rosand, and L.H. Schwamm Warfarin reversal in anticoagulant-associated intracerebral hemorrhage Neurocrit Care 9 2008 277 283
41. F.A. Ivascu, G.A. Howells, and F.S. Junn Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality J Trauma 59 2005 1131 1137 discussion 1137-1139
42. L.T. Goodnough, and A. Shander How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage Blood 117 2011 6091 6099
43. A.C. Logan, V. Yank, and R.S. Stafford Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records Ann Intern Med 154 2011 516 522
44. E. Simpson, Y. Lin, and S. Stanworth Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia Cochrane Database Syst Rev 3 2012 CD005011
45. E. Erhardtsen, P. Nony, and M. Dechavanne The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0 Blood Coagul Fibrinolysis 9 1998 741 748
46. B. Sorensen, P. Johansen, and G.L. Nielsen Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis:clinical and biochemical aspects Blood Coagul Fibrinolysis 14 2003 469 477
47. R.P. Rosovsky, and M.A. Crowther What is the evidence for the off-label use of recombinant factor VIIa (rFVIIa) in the acute reversal of warfarin? ASH evidence-based review 2008 Hematology Am Soc Hematol Educ Program 2008 36 38
48. T. Abshire, and G. Kenet Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors Haemophilia 14 2008 898 902
49. M.T. Robinson, A.A. Rabinstein, and J.F. Meschia Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system Stroke 41 2010 1459 1463
50. G.O. Thomas, R.P. Dutton, and B. Hemlock Thromboembolic complications associated with factor VIIa administration J Trauma 62 2007 564 569
51. C. Bartal, J. Freedman, and K. Bowman Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa J Trauma 63 2007 725 732
52. J.E. Beshay, H. Morgan, and C. Madden Emergency reversal of anticoagulation and antiplatelet therapies in neurosurgical patients J Neurosurg 112 2010 307 318
53. R.A. Deveras, and C.M. Kessler Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate Ann Intern Med 137 2002 884 888
54. W.E. Dager, J.H. King, and R.C. Regalia Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin Pharmacotherapy 26 2006 1091 1098
55. R. Altman, A. Scazziota, and M. de Lourdes Herrera The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications? Thromb J 8 2010 8
56. S.E. Lind, P.W. Callas, and E.A. Golden Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy Blood Coagul Fibrinolysis 8 1997 48 53
57. M. Hoffman Laboratory monitoring of high-dose factor VIIa therapy Ann Intern Med 139 2003 791
58. B.E. Skolnick, D.R. Mathews, and N.M. Khutoryansky Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects Blood 116 2010 693 701
59. N.S. Key, and C. Negrier Coagulation factor concentrates: past, present, and future Lancet 370 2007 439 448
60. B. Sorensen, D.R. Spahn, and P. Innerhofer Clinical review: prothrombin complex concentrates - evaluation of safety and thrombogenicity Crit Care 15 2011 201
61. G. Pernod, A. Godier, and C. Gozalo French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding) Thromb Res 126 2010 e167 e174
62. G. Liumbruno, F. Bennardello, and A. Lattanzio Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates Blood Transfus 7 2009 325 334
63. E.G. Butchart, C. Gohlke-Barwolf, and M.J. Antunes Recommendations for the management of patients after heart valve surgery Eur Heart J 26 2005 2463 2471
64. B. Berry, J. Callum, and M. Crowther Recommendations for use of Octaplex® in Canada. National Advisory Committee on Blood and Blood Products http://www.dsmanitoba.ca/professionals/transfusion/Octaplex-NACrecommendations. pdf 2008 Accessed March 3, 2013
65. M. Neal, M. Crowther, and J. Douketis Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice Thromb Res 122 2008 864 866
66. E.M. Liotta, R.K. Garg, and R.E. Temes Warfarin-associated intracerebral hemorrhage is inadequately treated at community emergency departments Stroke 43 2012 2503 2505
67. V. Aiyagari, and F.D. Testai Correction of coagulopathy in warfarin associated cerebral hemorrhage Curr Opin Crit Care 15 2009 87 92
68. C.A. Leissinger, P.M. Blatt, and W.K. Hoots Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature Am J Hematol 83 2008 137 143
69. J.H. Levy, K.A. Tanaka, and W. Dietrich Perioperative hemostatic management of patients treated with vitamin K antagonists Anesthesiology 109 2008 918 926
70. M. Makris, J.J. van Veen, and R. Maclean Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient J Thromb Thrombolysis 29 2010 171 181
71. C.J. Wiedermann, and I. Stockner Warfarin-induced bleeding complications - clinical presentation and therapeutic options Thromb Res 122 suppl 2 2008 S13 S18
72. B. Vigue Bench-to-bedside review: optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice Crit Care 13 2009 209
73. A.E. Patanwala, N.M. Acquisto, and B.L. Erstad Prothrombin complex concentrate for critical bleeding Ann Pharmacother 45 2011 990 999
74. J.P. Hanley Warfarin reversal J Clin Pathol 57 2004 1132 1139
75. A.C. Butler, and R.C. Tait Management of oral anticoagulant-induced intracranial haemorrhage Blood Rev 12 1998 35 44
76. T. Kuwashiro, M. Yasaka, and R. Itabashi Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage Cerebrovasc Dis 31 2011 170 176
77. F. Dentali, C. Marchesi, and M.G. Pierfranceschi Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis Thromb Haemost 106 2011 429 438
78. M. Franchini, and G. Lippi Prothrombin complex concentrates: an update Blood Transfus 8 2010 149 154
79. A. Majeed, A. Eelde, and A. Agren Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy Thromb Res 129 2012 146 151
80. C.H. Woo, N. Patel, and C. Conell Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate World Neurosurg 2013 10.1016/j.wneu.2012.12.002
81. N.A. Pinner, A.C. Hurdle, and C. Oliphant Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII World Neurosurg 74 2010 631 635
82. M. Yasaka, T. Sakata, and H. Naritomi Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation Thromb Res 115 2005 455 459
83. I. Pabinger-Fasching Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate Thromb Res 122 suppl 2 2008 S19 S22
84. I. Pabinger, B. Brenner, and U. Kalina Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial J Thromb Haemost 6 2008 622 631
85. M. Makris Optimisation of the prothrombin complex concentrate dose for warfarin reversal Thromb Res 115 2005 451 453
86. A. Lubetsky, R. Hoffman, and R. Zimlichman Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation Thromb Res 113 2004 371 378
87. D. Imberti, G. Barillari, and C. Biasioli Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage Pathophysiol Haemost Thromb 36 2008 259 265
88. D. Imberti, G. Barillari, and C. Biasioli Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage Blood Transfus 9 2011 148 155
89. L. Holland, T.E. Warkentin, and M. Refaai Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose Transfusion 49 2009 1171 1177
90. K.P. Cabral, G.L. Fraser, and J. Duprey Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding Clin Neurol Neurosurg 115 2013 770 774
91. C.T. Chong, T.W. Lew, and P. Kuperan Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates Anaesth Intensive Care 38 2010 474 480
92. R.M. Cusick, K. Matevosyan, and F. Aung Rapid warfarin reversal:combination of a 3-factor prothrombin complex concentrate and low dose recombinant FVIIa for traumatic intracranial hemorrhage Haemophilia 15 2009 630
93. R. Sarode, K. Matevosyan, and R. Bhagat Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage J Neurosurg 116 2012 491 497
94. J.H. Baggs, A.E. Patanwala, and E.M. Williams Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal Ann Pharmacother 46 2012 51 56
95. J.A. Switzer, J. Rocker, and P. Mohorn Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage Stroke 43 2012 2500 2502
96. S.A. Voils, and B. Baird Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: does it matter? Thromb Res 130 2012 833 840
97. A. Gatt, A. Riddell, and J.J. van Veen Optimizing warfarin reversal - an ex vivo study J Thromb Haemost 7 2009 1123 1127
98. M. Makris, and J.J. Van Veen Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal? Blood Transfus 9 2011 117 119
99. S. Ogawa, F. Szlam, and T. Ohnishi A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions Thromb Haemost 106 2011 1215 1223
100. D. Chiu, M. Grigg, and E. Levi Operating on patients with warfarin: simpler alternative approach ANZ J Surg 79 2009 409 410
101. J.H. Crawford, and B.M. Augustson Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed? Med J Aust 184 2006 365 366
102. H. Tran, M. Collecutt, and S. Whitehead Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation Intern Med J 41 2011 337 343
103. K. Fredriksson, B. Norrving, and L.G. Stromblad Emergency reversal of anticoagulation after intracerebral hemorrhage Stroke 23 1992 972 977
104. M. Makris, M. Greaves, and W.S. Phillips Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy Thromb Haemost 77 1997 477 480
105. N.M. Boulis, M.P. Bobek, and A. Schmaier Use of factor IX complex in warfarin-related intracranial hemorrhage Neurosurgery 45 1999 1113 1118 discussion 1118-1119
106. M. Cartmill, G. Dolan, and J.L. Byrne Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies Br J Neurosurg 14 2000 458 461
107. H.B. Huttner, P.D. Schellinger, and M. Hartmann Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates Stroke 37 2006 1465 1470
108. F. Siddiq, A. Jalil, and C. McDaniel Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage Neurocrit Care 8 2008 36 41
109. R. Demeyere, S. Gillardin, and J. Arnout Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study Vox Sang 99 2010 251 260
110. M.L. Vang, A.M. Hvas, and H.B. Ravn Urgent reversal of vitamin K antagonist therapy Acta Anaesthesiol Scand 55 2011 507 516
111. E.M. Bershad, and J.I. Suarez Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature Neurocrit Care 12 2010 403 413
112. R. Sarode, T.J. Milling, and M.A. Refaai Integrated safety analysis of a 4-factor prothrombin complex concentrate versus plasma in phase III clinical trials Poster presented at: Thrombosis and Hemostasis Summit of North America; Chicago, IL: May 3-5, 2012 http://cdn.f1000.com/posters/docs/249931755 Accessed March 3, 2013
113. G. Dickneite Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation Thromb Res 119 2007 643 651
114. S. Illanes, W. Zhou, and S. Schwarting Comparative effectiveness of hemostatic therapy in experimental warfarin-associated intracerebral hemorrhage Stroke 42 2011 191 195
115. F. Schlunk, E.M. Van Cott, and K. Hayakawa Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage Stroke 43 2012 246 249
116. T. Taketomi, F. Szlam, and J.H. Levy Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII Blood Coagul Fibrinolysis 19 2008 106 108
117. K.A. Tanaka, F. Szlam, and G. Dickneite Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation Thromb Res 122 2008 117 123
118. N.C. Mathijssen, R. Masereeuw, and K. Verbeek Prophylactic effect of recombinant factor VIIa in factor VII deficient patients Br J Haematol 125 2004 494 499
119. B. Tremey, K. Tazarourte, and C. Ract Teaching improves adherence to clinical guidelines in the treatment of oral anticoagulation-related severe bleeding in the emergency department Intensive Care Med 35 2009 1444 1448
120. A. Salamat, J. Seaton, and H.G. Watson Impact of introducing guidelines on anticoagulant reversal Transfus Med 15 2005 99 105
121. S.J. Evans, T.T. Biss, and R.H. Wells Emergency warfarin reversal with prothrombin complex concentrates: UK wide study Br J Haematol 141 2008 268 269
122. R. Appelboam, and E.O. Thomas The headache over warfarin in British neurosurgical intensive care units: a national survey of current practice Intensive Care Med 33 2007 1946 1953
123. G. Baldi, F. Altomonte, and M. Altomonte Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments Cerebrovasc Dis 22 2006 286 293
124. T. Desmettre, A.E. Dubart, and G. Capellier Emergency reversal of anticoagulation: the real use of prothrombin complex concentrates: a prospective multicenter two year French study from 2006 to 2008 Thromb Res 130 2012 e178 e183
125. G.M. Gaddis, P. Greenwald, and S. Huckson Toward improved implementation of evidence-based clinical algorithms: clinical practice guidelines, clinical decision rules, and clinical pathways Acad Emerg Med 14 2007 1015 1022
126. D.M. Stein, R.P. Dutton, and M.E. Kramer Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma J Trauma 66 2009 63 72 discussion 73-75
127. J.F. Guest, H.G. Watson, and S. Limaye Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom Clin Ther 32 2010 2478 2493
128. P. Toy, M.A. Popovsky, and E. Abraham Transfusion-related acute lung injury:definition and review Crit Care Med 33 2005 721 726
129. R.W. Toner, L. Pizzi, and B. Leas Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services Appl Health Econ Health Policy 9 2011 29 37
130. I. Veshchev, H. Elran, and K. Salame Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma Med Sci Monit 8 2002 CS98 CS100
131. J. Islam, S. Azhar, and J.B. Alperin Recombinant factor VIIa for uncontrolled bleeding in 2 different cases of coagulopathy J Am Board Fam Pract 16 2003 549 552
132. J. Sanchis Cervera, C.J. Andres Blasco, and A.V. Mena-Duran Treatment of acute bleeding with recombinant factor VIIa in a patient with IgA deficit receiving anticoagulant therapy Acta Haematol 110 2003 51 52
133. S.A. Carnazzo, R. Saitta, and G.M. Laurentini Use of recombinant activated factor VII in an elderly female undergoing acenocoumarol thromboprophylaxis requiring an emergency laparotomy J Thromb Thrombolysis 19 2005 213 214
134. S. Conti, D. La Torre, and G. Gambelunghe Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves Clin Lab Haematol 27 2005 283 285
135. C.C. Ionita, J. Ferrara, and D.L. McDonagh Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage Neurocrit Care 3 2005 246 248
136. A. Talkad, M. Mathews, and D. Honings Reversal of warfarin-induced anticoagulation with factor VIIa prior to rt-PA in acute stroke Neurology 64 2005 1480 1481
137. L. Morante, E.V. Guasch, and F. Palacio Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery Anesth Analg 102 2006 1902 1903
138. R. Goldberg, and K.J. Drummond Recombinant activated factor VII for a warfarinised Jehovah's Witness with an acute subdural haematoma J Clin Neurosci 15 2008 1164 1166
139. D.M. Kalainov, and L.A. Valentino Recombinant activated factor VII as a temporary reversal agent for warfarin anticoagulation: a cautionary report on an off-label application Am J Orthop (Belle Mead NJ) 37 2008 572 574
140. G.M. Testerman, S. Shilad, and K.J. George Rapid warfarin reversal with factor VIIa in an elderly trauma patient with retroperitoneal hematoma Tenn Med 102 2009 37 39
141. J. Lin, W.C. Hanigan, and M. Tarantino The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings J Neurosurg 98 2003 737 740
142. P. Park, M.E. Fewel, and H.J. Garton Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients Neurosurgery 53 2003 34 38 discussion 38-39
143. B. Sorensen, P. Johansen, and G.L. Nielsen Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects Blood Coagul Fibrinolysis 14 2003 469 477
144. W.D. Freeman, T.G. Brott, and K.M. Barrett Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage Mayo Clin Proc 79 2004 1495 1500
145. S. Zupancic-Salek, J. Kovacevic-Metelko, and I. Radman Successful reversal of anticoagulant effect of superwarfarin poisoning with recombinant activated factor VII Blood Coagul Fibrinolysis 16 2005 239 244
146. N. Da'as, M. Misgav, and Y. Kalish Recombinant factor VIIa for rapid reversal of anticoagulant effect in patients with intracranial hemorrhage: the Israeli experience and review of the literature Isr Med Assoc J 8 2006 807 811
147. J. Ingerslev, T. Vanek, and S. Culic Use of recombinant factor VIIa for emergency reversal of anticoagulation J Postgrad Med 53 2007 17 22
148. N. McQuay Jr., J. Cipolla, and E.Z. Franges The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial? J Neurosurg 111 2009 666 671
149. M.T. Robinson, A.A. Rabinstein, and J.F. Meschia Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system Stroke 41 2010 1459 1463
150. R. Sarode, K. Matevosyan, and R. Bhagat Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage J Neurosurg 116 2012 491 497
151. D.L. Brody, V. Aiyagari, and A.M. Shackleford Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage Neurocrit Care 2 2005 263 267
152. C. Ilyas, G.M. Beyer, and R.P. Dutton Recombinant factor VIIa for warfarin-associated intracranial bleeding J Clin Anesth 20 2008 276 279
153. D.M. Stein, R.P. Dutton, and M.E. Kramer Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury J Trauma 64 2008 620 627 discussion 627-628
154. D.M. Stein, R.P. Dutton, and J.R. Hess Low-dose recombinant factor VIIa for trauma patients with coagulopathy Injury 39 2008 1054 1061
155. D.M. Stein, R.P. Dutton, and M.E. Kramer Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma J Trauma 66 2009 63 72 discussion 73-65
156. C.V. Brown, K.H. Foulkrod, and D. Lopez Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients J Trauma 68 2010 348 352
157. D.K. Nishijima, W.E. Dager, and R.J. Schrot The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage Acad Emerg Med 17 2010 244 251
158. N.A. Pinner, A.C. Hurdle, and C. Oliphant Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII World neurosurgery 74 2010 631 635
159. C.H. Woo, N. Patel, and C. Conell Rapid Warfarin Reversal in the Setting of Intracranial Hemorrhage: A Comparison of Plasma, Recombinant Activated Factor VII, and Prothrombin Complex Concentrate World neurosurgery 2013 http://dx.doi.org/10.1016/j.wneu.2012.12.002
160. G. Muleo, R. Santoro, and P.G. Iannaccaro Small doses of recombinant factor VIIa in acquired deficiencies of vitamin K dependent factors Blood Coagul Fibrinolysis 10 1999 521 522
161. R.A. Deveras, and C.M. Kessler Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate Ann Intern Med 137 2002 884 888
162. R.P. Dutton, M. McCunn, and M. Hyder Factor VIIa for correction of traumatic coagulopathy J Trauma 57 2004 709 718 discussion 718-709
163. B. Roitberg, O. Emechebe-Kennedy, and S. Amin-Hanjani Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study Neurosurgery 57 2005 832 836 discussion 832-836
164. W.E. Dager, J.H. King, and R.C. Regalia Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin Pharmacotherapy 26 2006 1091 1098
165. C. Bartal, J. Freedman, and K. Bowman Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa J Trauma 63 2007 725 732
166. R.M. Cusick, K. Matevosyan, and F. Aung Rapid warfarin reversal: combination of a 3-factor prothrombin complex concentrate and low dose recombinant FVIIa for traumatic intracranial hemorrhage Haemophilia 15 2009 630
167. M. Yasaka, M. Oomura, and K. Ikeno Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose Ann Hematol 82 2003 121 123
168. O. Warren, and B. Simon Massive, fatal, intracardiac thrombosis associated with prothrombin complex concentrate Ann Emerg Med 53 2009 758 761
169. Y. Morimoto, H. Niwa, and T. Nakatani On the use of prothrombin complex concentrate in patients with coagulopathy requiring tooth extraction Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110 2010 e7 e10
170. Y. Wong Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage Clin Med Insights Case Rep 4 2011 1 6
171. I.C. Nitu, D.J. Perry, and C.A. Lee Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal Clin Lab Haematol 20 1998 363 367
172. L. Sjoblom, H.G. Hardemark, and A. Lindgren Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study Stroke 32 2001 2567 2574
173. D. Bruce, and T.J. Nokes Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital Crit Care 12 2008 R105
174. D. Chiu, M. Grigg, and E. Levi Operating on patients with warfarin: simpler alternative approach ANZ J Surg 79 2009 409 410
175. M.N. Safaoui, R. Aazami, and H. Hotz A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage Am J Surg 197 2009 785 790
176. K.S. Schick, J.M. Fertmann, and K.W. Jauch Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding Crit Care 13 2009 R191
177. C.T. Chong, T.W. Lew, and P. Kuperan Rapid reversal of coagulopathy in warfarin-related intracranial haemorrhages with prothrombin complex concentrates Anaesth Intensive Care 38 2010 474 480
178. K.P. Cabral, G.L. Fraser, and J. Duprey Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding Clinical neurology and neurosurgery 115 2013 770 774
179. R. Sarode, K. Matevosyan, and R. Bhagat Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage J Neurosurg 116 2012 491 497
180. M.M. Song, C.P. Warne, and M.A. Crowther Prothrombin complex concentrate (PCC, Octaplex(R)) in patients requiring immediate reversal of vitamin K antagonist anticoagulation Thromb Res 129 2012 526 529
181. J.A. Switzer, J. Rocker, and P. Mohorn Clinical experience with three-factor prothrombin complex concentrate to reverse warfarin anticoagulation in intracranial hemorrhage Stroke 43 2012 2500 2502
182. K. Fredriksson, B. Norrving, and L.G. Stromblad Emergency reversal of anticoagulation after intracerebral hemorrhage Stroke 23 1992 972 977
183. M. Makris, M. Greaves, and W.S. Phillips Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy Thromb Haemost 77 1997 477 480
184. M. Yasaka, T. Sakata, and K. Minematsu Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication Thromb Res 108 2003 25 30
185. J.H. Crawford, and B.M. Augustson Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed? Med J Aust 184 2006 365 366
186. H.B. Huttner, P.D. Schellinger, and M. Hartmann Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates Stroke 37 2006 1465 1470
187. M.W. Lankiewicz, J. Hays, and K.D. Friedman Urgent reversal of warfarin with prothrombin complex concentrate J Thromb Haemost 4 2006 967 970
188. P. Junagade, R. Grace, and P. Gover Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy Hematology 12 2007 439 440
189. F. Siddiq, A. Jalil, and C. McDaniel Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage Neurocrit Care 8 2008 36 41
190. C. WójciWójcik, M.L. Schymik, and E.G. Cure Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy Int J Emerg Med 2 2009 217 225
191. N.A. Pinner, A.C. Hurdle, and C. Oliphant Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII World neurosurgery 74 2010 631 635
192. S.A. Chapman, E.D. Irwin, and A.L. Beal Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin Ann Pharmacother 45 2011 869 875
193. J.H. Baggs, A.E. Patanwala, and E.M. Williams Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal Ann Pharmacother 46 2012 51 56
194. G. Barillari, S. Pasca, and A. Barillari Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience Blood Transfus 10 2012 87 94
195. C.H. Woo, N. Patel, and C. Conell Rapid Warfarin Reversal in the Setting of Intracranial Hemorrhage: A Comparison of Plasma, Recombinant Activated Factor VII, and Prothrombin Complex Concentrate World neurosurgery 2013 10.1016/j.wneu.2012.12.002
196. S.G. Sandler, C.E. Rath, and A. Ruder Prothrombin complex concentrates in acquired hypoprothrombinemia Ann Intern Med 79 1973 485 491
197. T. Staudinger, M. Frass, and C. Rintelen Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients Intensive Care Med 25 1999 1105 1110
198. M. Cartmill, G. Dolan, and J.L. Byrne Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies Br J Neurosurg 14 2000 458 461
199. G. Evans, R. Luddington, and T. Baglin Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding Br J Haematol 115 2001 998 1001
200. F.E. Preston, S.T. Laidlaw, and B. Sampson Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients Br J Haematol 116 2002 619 624
201. A. Lubetsky, R. Hoffman, and R. Zimlichman Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation Thromb Res 113 2004 371 378
202. E. Lavenne-Pardonge, M.A. Itegwa, and M. Kalaai Emergency reversal of oral anticoagulation through PPSB-SD: the fastest procedure in Belgium Acta Anaesthesiol Belg 57 2006 121 125
203. R. Lorenz, J. Kienast, and U. Otto Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study Blood Coagul Fibrinolysis 18 2007 565 570
204. H.B. Riess, A. Meier-Hellmann, and J. Motsch Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation Thromb Res 121 2007 9 16
205. B. Vigue, C. Ract, and B. Tremey Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage Intensive Care Med 33 2007 721 725
206. D. Imberti, G. Barillari, and C. Biasioli Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage Pathophysiol Haemost Thromb 36 2008 259 265
207. M. Kalina, G. Tinkoff, and A. Gbadebo A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy Am Surg 74 2008 858 861
208. I. Pabinger-Fasching Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate Thromb Res 122 Suppl 2 2008 S19 S22
209. R.M. Cusick, K. Matevosyan, and F. Aung Rapid warfarin reversal: combination of a 3-factor prothrombin complex concentrate and low dose recombinant FVIIa for traumatic intracranial hemorrhage Haemophilia 15 2009 630
210. L. Holland, T.E. Warkentin, and M. Refaai Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose Transfusion 49 2009 1171 1177
211. N. Khorsand, N.J. Veeger, and M. Muller Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy Transfus Med 21 2011 116 123
212. I. Pabinger, A. Tiede, and U. Kalina Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal Ann Hematol 89 2010 309 316
213. T. Rizos, E. Jenetzky, and C. Herweh Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage Neurocrit Care 13 2010 321 325
214. H. Tran, M. Collecutt, and S. Whitehead Prothrombin Complex Concentrates Used Alone in Urgent Reversal of Warfarin Anticoagulation Intern Med J 41 2011 337 343
215. D. Imberti, G. Barillari, and C. Biasioli Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage Blood Transfus 9 2011 148 155
216. T. Desmettre, A.E. Dubart, and G. Capellier Emergency reversal of anticoagulation: The real use of prothrombin complex concentrates: A prospective multicenter two year French study from 2006 to 2008 Thromb Res 130 2012 e178 e183
217. M. Yasaka, T. Sakata, and H. Naritomi Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation Thromb Res 115 2005 455 459
218. T. Kuwashiro, M. Yasaka, and R. Itabashi Effect of Prothrombin Complex Concentrate on Hematoma Enlargement and Clinical Outcome in Patients with Anticoagulant-Associated Intracerebral Hemorrhage Cerebrovasc Dis 31 2011 170 176
219. N. Khorsand, N.J. Veeger, and R.M. van Hest An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies Haematologica 97 2012 1501 1506
220. A. Majeed, A. Eelde, and A. Agren Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy Thromb Res 129 2012 146 151
221. D.A. Taberner, J.M. Thomson, and L. Poller Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal Br Med J 2 1976 83 85
222. N.M. Boulis, M.P. Bobek, and A. Schmaier Use of factor IX complex in warfarin-related intracranial hemorrhage Neurosurgery 45 1999 1113 1118 discussion 1118-1119
223. L. van Aart, H.W. Eijkhout, and J.S. Kamphuis Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial Thromb Res 118 2006 313 320
224. R. Demeyere, S. Gillardin, and J. Arnout Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study Vox Sang 99 2010 251 260
225. R. Sarode, T.J. Milling, and M.A. Refaai Integrated safety analysis of a 4-factor prothrombin complex concentrate versus plasma in phase III clinical trials Poster presented at Thrombosis and Hemostasis Summit of North America. Chicago, IL: May 3-5, 2012 http://cdn.f1000.com/posters/docs/249931755 (Accessed March 3, 2013)
226. J.N. Goldstein Beriplex outperforms plasma for rapid warfarin reversal Presented at the Scientific Assembly of the American College of Emergency Physicians. Denver, CO: October 8-11, 2012 http://www.acepnews.com/specialty- focus/toxicology/single-article-page/beriplex-outperforms-plasma-for-rapid- warfarin-reversal/f841ecd78971e82c1fb2ec9ad5dec4fc.html (Accessed March 3, 2013)